The cytokine profile of primary coronary artery endothelial cells cultivated in the presence of doxorubicin (2 μg/ml and 6 μg/ml) was evaluated using enzyme-linked immunosorbent assay and qPCR. Cultivation of cells in the presence of these concentrations of doxorubicin for 24 h, upregulated expression of the following genes: IL6 (by 2.30 and 2.66 times, respectively), IL1B (by 1.25 and 3.44 times), and CXCL8 (by 6.47 times and 6.42 times), MIF (2.34 and 2.28 times), CCL2 (4.22 and 3.98 times). Under these conditions the following genes were downregulated: IL10, IL1R2, TNF. Cultivation of cells in the presence of doxorubicin (2 μg/ml and 6 μg/ml) for 24 h also increased the secretion of IL-6.
Sinitskaya A.V., Velikanova E.A., Senokosova E.A., Sinitsky M.Yu., Khutornaya M.V., Asanov M.A., Poddubnyak A.O., Ponasenko A.V. (2024) The cytokine response of human coronary artery endothelial cells treated with doxorubicin: results of an in vitro experiment. Biomeditsinskaya Khimiya, 70(3), 156-160.
Sinitskaya A.V. et al. The cytokine response of human coronary artery endothelial cells treated with doxorubicin: results of an in vitro experiment // Biomeditsinskaya Khimiya. - 2024. - V. 70. -N 3. - P. 156-160.
Sinitskaya A.V. et al., "The cytokine response of human coronary artery endothelial cells treated with doxorubicin: results of an in vitro experiment." Biomeditsinskaya Khimiya 70.3 (2024): 156-160.
Sinitskaya, A. V., Velikanova, E. A., Senokosova, E. A., Sinitsky, M. Yu., Khutornaya, M. V., Asanov, M. A., Poddubnyak, A. O., Ponasenko, A. V. (2024). The cytokine response of human coronary artery endothelial cells treated with doxorubicin: results of an in vitro experiment. Biomeditsinskaya Khimiya, 70(3), 156-160.
References
Wenningmann N., Knapp M., Ande A., Vaidya T.R., Ait-Oudhia S. (2019) Insights into doxorubicin-induced cardiotoxicity: Molecular mechanisms, preventive strategies, and early monitoring. Mol. Pharmacol., 96(2), 219–232. CrossRef Scholar google search
Luu A.Z., Chowdhury B., Al-Omran M., Teoh H., Hess D.A., Verma S. (2018) Role of endothelium in doxorubicininduced cardiomyopathy. JACC Basic Transl. Sci., 3(6), 861–870. CrossRef Scholar google search
McGowan J.V., Chung R., Maulik A., Piotrowska I., Walker J.M., Yellon D.M. (2017) Anthracycline chemotherapy and cardiotoxicity. Cardiovasc. Drugs Ther., 31(1), 63–75. CrossRef Scholar google search
Sinitsky M.Yu., Tsepokina A.V., Khutornaya M.V., Ponasenko A.V., Sumin A.N. (2021) Genetic basis of anthracyclines cardiotoxicity: Literature review. Acta Biomedica Scientifica, 6(4), 27–38. CrossRef Scholar google search
Ivanov A.N., Popyhova E.B., Tereshkina N.Ye., Stepanova T.V., Zlobina O.V., Norkin I.A. (2020) Vasomotor function of endothelium. Uspekhi Fiziologicheskikh Nauk, 51(4), 82–104. CrossRef Scholar google search
Podyacheva E., Danilchuk M., Toropova Y. (2023) Molecular mechanisms of endothelial remodeling under doxorubicin treatment. Biomed. Pharmacother., 162, 114576. CrossRef Scholar google search
Shi S., Chen Y., Luo Z., Nie G., Dai Y. (2023) Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy. Cell Commun. Signal., 21(1), 61. CrossRef Scholar google search
OECD (2016) Test No. 487: In vitro mammalian cell micronucleus test, OECD guideline for the testing of chemicals, Section 4, OECD Publishing. Scholar google search
Sinitsky M.Yu., Tsepokina A.V., Kutikhin A.G., Shishkova D.K., Ponasenko A.V. (2021) The gene expression signature in endothelial cells exposed to mitomycin C. Biomeditsinskaya Khimiya, 67(2), 130–136. CrossRef Scholar google search
Pfaffl M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic. Acids Res., 29(9), e45. CrossRef Scholar google search
Sinitsky M.Yu., Tsepokina A.V., Kutikhin A.G., Shishkova D.K., Ponasenko A.V. (2020) Secretion and gene expression of proatherosclerotic cytokines IL6 and IL8 by endothelial cells exposed to mutagen. Medical Genetics, 19(12), 38–46. CrossRef Scholar google search
Kutikhin A.G., Shishkova D.K., Sinitsky M.Yu., Velikanova E.A. (2020) Calcium phosphate bions cause increased release of interleukin-6 and interleukin-8 in primary arterial endothelial cells regardless of their shape. Pathogenesis, 18(2), 53–60. CrossRef Scholar google search
Gallo G., Savoia C. (2024) New insights into endothelial dysfunction in cardiometabolic diseases: Potential mechanisms and clinical implications. Int. J. Mol. Sci., 25(5), 2973. CrossRef Scholar google search
Sumaiya K., Langford D., Natarajaseenivasan K., Shanmughapriya S. (2022) Macrophage migration inhibitory factor (MIF): A multifaceted cytokine regulated by genetic and physiological strategies. Pharmacol. Ther., 233, 108024. CrossRef Scholar google search
Cheng Q., McKeown S.J., Santos L., Santiago F.S., Khachigian L.M., Morand E.F., Hickeyacrophage M.J. (2010) Migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. J. Immunol., 185(2), 1238–1247. CrossRef Scholar google search
Ivanova G.T. (2022) Effect of doxorubicin on the reactivity of rat mesenteric arteries. J. Evol. Biochem. Phys., 58, 1914–1925. CrossRef Scholar google search
He H., Wang L., Qiao Y., Zhou Q., Li H., Chen S., Yin D., Huang Q., He M. (2020) Doxorubicin induces endotheliotoxicity and mitochondrial dysfunction via ROS/eNOS/NO pathway. Front. Pharmacol., 10, 1531. CrossRef Scholar google search
Gibson N.M., Greufe S.E., Hydock D.S., Hayward R. (2013) Doxorubicin-induced vascular dysfunction and its attenuation by exercise preconditioning. J. Cardiovasc. Pharmacol., 62, 355–360. CrossRef Scholar google search
Olukman M., Can C., Erol A., Oktem G., Oral O., Cinar M.G. (2009) Reversal of doxorubicin-induced vascular dysfunction by resveratrol in rat thoracic aorta: Is there a possible role of nitric oxide synthase inhibition? Anadolu Kardiyoloji Dergisi, 9, 260–266. Scholar google search
Bosman M., Krüger D.N., Favere K., Wesley C.D., Neutel C.H.G., van Asbroeck B., Diebels O.R., Faes B., Schenk T.J., Martinet W., de Meyer G.R.Y., van Craenenbroeck E.M., Guns P.-J.D.F. (2021) Doxorubicin impairs smooth muscle cell contraction: Novel insights in vascular toxicity. Int. J. Mol. Sci., 22(23), 12812. CrossRef Scholar google search
